A lawsuit from the state of Colorado claims Purdue Pharma, which earned $35 billion in opioid manufacturing and sales, aimed its marketing to create doubt that opioids should be used sparingly.


52
Thanks for voting


USA Today

12 Related Articles, between 2018-09-10 and 2018-09-09